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Abstract: Platelet-rich fibrin (PRF) is a blood concentrate derived from venous blood that is processed
without anticoagulants by a one-step centrifugation process. This three-dimensional scaffold contains
inflammatory cells and plasma proteins entrapped in a fibrin matrix. Liquid-PRF was developed based
on the previously described low-speed centrifuge concept (LSCC), which allowed the introduction of
a liquid-PRF formulation of fibrinogen and thrombin prior to its conversion to fibrin. Liquid-PRF was
introduced to meet the clinical demand for combination with biomaterials in a clinically applicable
and easy-to-use way. The aim of the present study was to evaluate, ex vivo, the interaction of the
liquid-PRF constituents with five different collagen biomaterials by histological analyses. The results
first demonstrated that large variability existed between the biomaterials investigated. Liquid-PRF
was able to completely invade Mucograft® (MG; Geistlich Biomaterials, Wolhusen, Switzerland) and
to partly invade Bio-Gide® (BG; Geistlich Biomaterials, Wolhusen, Switzerland) and Mucoderm®
(MD; Botiss Biomaterials, Berlin, Germany), and Collprotect® (CP; Botiss Biomaterials, Berlin,
Germany) showed only a superficial interaction. The BEGO® collagen membrane (BCM; BEGO
Implant Systems) appeared to be completely free of liquid-PRF. These results were confirmed by the
different cellular penetration and liquid-PRF absorption coefficient (PAC) values of the evaluated
membranes. The present study demonstrates a system for loading biomaterials with a complex
autologous cell system (liquid-PRF) in a relatively short period of time and in a clinically relevant
manner. The combination of biomaterials with liquid-PRF may be clinically utilized to enhance
the bioactivity of collagen-based biomaterials and may act as a biomaterial-based growth factor
delivery system.
Keywords: collagen; leukocytes; platelets; platelet-rich fibrin; tissue engineering; centrifugation;
liquid-PRF; LSCC
1. Introduction
The function of biomaterials in regenerative medicine is to support soft and hard tissue regeneration
through material-induced tissue reactions. When looking for the “ideal” biomaterial, several
requirements must be considered, including tissue compatibility, physiochemical stability, the rates
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of vascularization and degradation, and the biomaterial-specific immune response [1]. Recently,
various collagen-based biomaterials were introduced for use in guided bone and tissue regeneration
(GBR/GTR). These materials are mostly resorbable, naturally derived collagenous biomaterials mainly
with xenogeneic origins. Previous in vivo experiments evaluated the cellular reaction towards
collagen-based biomaterials after subcutaneous implantation [2]. Different types of tissue reactions
were observed, including the induction of mononuclear cells (MNCs), such as monocytes, lymphocytes,
macrophages, and fibroblasts, or signs of a foreign body reaction, which is characterized by the
formation of additional multinucleated giant cells (MNGCs) [2,3].
In vivo evaluation of a porcine-derived bilayer collagen membrane showed stepwise integration,
inducing only MNCs, over a 60-day period [4]. Analysis of the vascularization rate revealed a mild
vascularization pattern without material penetration, which emphasizes the ability of collagen-based
biomaterials to integrate within the implantation region without undergoing transmembranous
vascularization [4,5]. Additional investigations evaluating porcine-derived collagenous membranes of
different thicknesses and physiochemical compositions revealed the presence of MNGCs. In these cases,
the occurrence of MNGCs was associated with an enhanced vascularization rate and disintegration of
the membranes accompanied by premature ingrowth of the peri-implantation region into the central
region of the biomaterials [6,7]. These observations showed that although all biomaterials were derived
from the same origin, different cellular reactions were induced based on their processing techniques
and physicochemical properties.
The role of collagen-based biomaterials in GBR has been explored in vivo, showing the crucial
influence of new bone formation when comparing bony defects covered with a collagen membrane to
those without collagen membranes [8]. However, the biomaterial characteristics may influence the
underlying bone area. Several investigations have confirmed the function of different collagen-based
biomaterials as bioactive components involved in bone regeneration in combination with different
bone substitutes [9]. These findings are relevant for clinical applications of pure biomaterials [10,11].
Moreover, previously published, in vivo cell-based, tissue engineering studies that considered the use
of biological concepts, such as the combination of biomaterials with primary human cells or pre-seeding
with monocytes, have demonstrated their effects on the vascularization patterns in the biomaterials
at hand, and the consequently enhanced regenerative capacities [12]. However, cell-based tissue
engineering is a sensitive technique that requires special conditions, which are mostly not available in
clinical settings. A clinically applicable system was, therefore, highly needed to reap the benefits of
these observations.
This blood concentrate is derived from the patient’s peripheral blood after a one-step centrifugation
without anticoagulants to generate a platelet and leucocyte-rich matrix. The presence of platelets,
leucocytes, and fibrin was previously shown to be essential for wound healing [13,14]. In addition to the
potential of leucocytes to influence angiogenesis and lymphomagenesis, this fibrin network, containing
leucocytes and platelets, is a source of cytokines and growth factors, which are the main players in the
process of wound healing [15]. The use of specific plastic tubes favors nonclotting platelet-rich fibrin
(PRF) and results in the development of a liquid-PRF-based matrix (liquid-PRF) produced without
the need for anticoagulants. Previously, a systematic study investigated the influence of the applied
relative centrifugal force (RCF) on the composition and bioactivity of PRF matrices [16]. In that study,
it was shown that liquid-PRF generated with the lowest RCF contained the highest concentration of
platelets and leukocytes and released significantly higher concentrations of different growth factors
compared to two other liquid-PRF matrices prepared at higher RCF [16]. Therefore, the low-speed
centrifugation concept (LSCC) was described to standardize the centrifugation of blood concentrates.
The combination of autologous biological products; i.e., PRF-based matrices with xenogeneic
biomaterials, has been of great clinical interest. The application of PRF matrices with different
centrifugation protocols in combination with collagen-based biomaterials was previously described in
several clinical studies, especially in periodontology [17]. However, the results are not consistent. Some
studies showed a positive effect of the addition of PRF to collagen-based biomaterials, while others did
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not show any effect [18]. It may be that the biomaterial-specific physicochemical characteristics, such as
surface structure, absorption capacity, porosity, and thickness, may influence the interaction between
the collagen-based biomaterial and PRF. However, to date, no published studies have evaluated the
feasibility of combining collagen-based biomaterials and PRF in detail. Therefore, the aim of the
present study was to evaluate the interaction of liquid-PRF with five different collagenous biomaterials
by histological analyses to identify the most promising combination for clinical use. To the best
of our knowledge, this was the first study to analyze the combination of different commercially
available collagen-based biomaterials and liquid-PRF ex vivo. Particular attention was focused on the
absorption capacities and penetration patterns of the leucocytes and platelets within the collagen-based
biomaterials after liquid-PRF application, and on the interaction between collagen and fibrin.
2. Materials and Methods
In the present study, five different commercially available collagen-based biomaterials were used.
2.1. Collagen Membranes
Mucograft® (MG; Geistlich Biomaterials, Wolhusen, Switzerland) is a bilayered collagen matrix
derived from porcine peritoneum and skin. The collagen is derived from a certified porcine source and
is processed to purify it from genetically active constituents. The matrix consists of type I and type III
collagen and is processed using standardized methods and sterilized by gamma irradiation without
chemical treatment or additional cross-linking. The bilayered structure of the matrix consists of a thin,
smooth, compact layer with low porosity and a three-dimensional spongy layer with higher porosity.
These layers are connected using a biophysical interweaving process. The pore system of the matrix
is manufactured via defined parameters and lyophilization to include both small and large pores
(5–200 µm). This variously-sized pores serve as a matrix for tissue and cell adherence and stabilize the
blood clot after application.
Bio-Gide® (BG; Geistlich Biomaterials, Wolhusen, Switzerland) is a porcine-derived collagen
membrane containing type I and III collagen without cross-linking. This bilayered membrane
is manufactured using a standardized process to eliminate immunologically active constituents,
microorganisms, and other residues. Collagen is obtained from a veterinary-certified porcine source
and is sterilized by gamma irradiation. The pure bilayered collagen membrane consists of a smooth, thin,
compact layer with low porosity and a three-dimensional, more porous spongy layer. This structure
should support bone formation and inhibit connective tissue ingrowth in bony defects.
Mucoderm® (MD; Botiss Biomaterials, Berlin, Germany) is a porcine dermis-based collagen
matrix. The membrane is purified by a multistep cleaning method, lyophilized, and sterilized by
gamma irradiation to produce a three-dimensional non-cross-linked membrane of collagen and elastin.
Collprotect® (CP; Botiss Biomaterials, Berlin, Germany) is a bilayered cross-linked collagen
membrane containing type I and type III collagen and elastin. The membrane is obtained from porcine
dermis. Purification methods, such as multistep cleaning, lyophilization, and gamma irradiation, were
performed to generate a stable three-dimensional bilayered collagen membrane.
BEGO® collagen membrane (BCM; BEGO Implant Systems) is a non-cross-linked, stratified
membrane obtained from porcine pericardium. Donor animals are selected in a veterinary-controlled
porcine source. The extracted collagen is treated by a controlled purification process, lyophilized, and
sterilized with ethylene oxide gas.
2.2. Scanning Electron Microscopy
The ultrastructure of the collagen-based biomaterials was examined under a DSM 962 SEM
(scanning electron microscope, Zeiss, Oberkochen, Germany) operated with a LaB6 cathode, which can
be used to obtain medium resolution photographs. After sputter coating the samples with 20–30 nm
gold in a cold sputter unit, images were taken at 10 keV acceleration energy and an object distance
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of approximately 12.0 cm. The SEM images were analyzed with the Kontron KS 300 image analysis
program (Carl Zeiss Vision, Eching, Germany).
2.3. Liquid-PRF Preparation
The application of PRF in this study was approved by the responsible Ethics Commission of the
state of Hessen, Germany (265/17). Liquid-PRF was obtained from venous blood without additional
anticoagulants as previously described [16]. Three healthy volunteers, aged 18–50 years with no
anticoagulant usage, donated peripheral blood for this study after informed consent was obtained. Four
sterile, 10 mL plastic tubes (Process for PRF, France, radius 110 mm) full of blood were obtained from
each participant. The filled tubes were immediately placed in the centrifuge, with two tubes placed
directly opposite each other for balance during centrifugation. The liquid centrifugation protocol
(10 mL, 600 rpm, 44 × g for 8 min) according to LSCC was performed in a programmed centrifuge
(Duo centrifuge; PROCESS for PRF, Nice, France). The tubes that were used did not contain any
type of anticoagulants in order to avoid interference with platelet activity. After centrifugation, the
tubes showed a multiphasic liquid that contained an upper phase of a yellow–orange-colored liquid
(liquid-PRF) and a lower red phase of the remaining blood constituents. The tubes were carefully
opened to avoid mixing the phases, and 1–2 mL of the upper liquid (liquid-PRF) was collected using a
10 mL syringe with a needle (B Braun inject®) and transferred to a flask.
2.4. Liquid-PRF Application
Four samples (10 × 10 mm) were prepared from each collagenous biomaterial using scissors.
The material sample was placed on a 4 × 6 cell culture plate, and the prepared 500 µL liquid-PRF was
applied to the collagen-based biomaterial samples, covering the entire sample. The membranes were
kept in liquid-PRF until clotting (15 min at room temperature). Then, the samples were fixed in 4%
formaldehyde for 24 h.
2.5. Histological Preparation
The fixed samples were processed according to previously described techniques [5]. Briefly, after
processing, six 3–4 µm sections were cut from each sample using a rotary microtome (Leica RM2255;
Wetzlar, Germany). Next, the samples were stained with different histochemical stains. The first slice
was stained with hematoxylin and eosin (H&E) according to standard protocols, and the other five
slices were stained with Azan–Mallory, Masson–Goldner, and Giemsa.
2.6. Histological Analysis
Morphological and qualitative histological analyses of the prepared slices were performed using
a Nikon ECLIPSE 80i microscope (Tokyo, Japan). We focused on the interaction with liquid-PRF,
particularly the locations and distributions of leucocytes and platelets, and the liquid-PRF invasion of
the biomaterials. Additionally, histological photographs were captured using a Nikon DS-Fi1/Digital
camera with a digital sight control unit.
2.7. Histomorphometrical and Statistical Analysis
Four Giemsa-stained slides of each biomaterial were used for the histomorphometric analysis of
cellular penetration. Total scans were created using a light microscope (Nikon, Tokyo, Japan) with a
scanning table (Prior, Rockland, MA, USA) connected to a DS-Fi/1 digital camera (Nikon) and a PC
running NIS Elements AR software (version 4.1; Nikon). A total scan is a merge of 50–100 single images
of the region of interest. Subsequently, the thickness of the biomaterials was measured (in µm) using
the measurement tools in NIS Elements. The penetration distance into the biomaterials was measured
in µm. Cellular penetration into the central region (thickness/2) of the biomaterial was set to 100%.
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2.8. Fluid Absorption Capacity
The capacity of each biomaterial to absorb liquid-PRF was measured using a gravimetric method
and named the PRF absorption coefficient (PAC). This method was based on the difference in sample
weight before versus after the application of a specific liquid. In this experiment, two different
liquids were tested: distilled water and liquid-PRF. Three segments of 0.8 mm diameter (d) from
each biomaterial were extracted using biopsy punches (SmithKline Beecham, NW, UK) weighed in a
dry state (W0) and then placed in 24-well cell culture plates. Five hundred microliters of liquid-PRF
were deposited on top of the biomaterials; incubation for 15 min at room temperature was then
performed—until clotting. The weight of the biomaterials after incubation was registered (W1), and the
absorption coefficient was calculated using the following formula: PAC = (W1 − W0)/W0. The same
procedure was repeated with distilled water as a control measurement (WAC).
2.9. Statistical Analysis
The results are expressed as the means and standard deviations. GraphPad Prism 7 (GraphPad
Software, Inc., La Jolla, USA) was used to generate charts and perform statistical analyses using
one-way analysis of variance with Tukey’s multiple comparisons test (α= 0.05). Values were considered
significant if p < 0.05 (*) and highly significant at p < 0.01 (**), p < 0.001 (***), and p < 0.0001 (****).
3. Results
The results revealed the structural details of the biomaterials before combination with PRF to
evaluate differences in the physical structures ex vivo. This may be relevant to understanding the
interaction between the material and liquid-PRF, as described in the following sections.
3.1. Ultrastructure of the Collagen-Based Biomaterials without PRF
Mucograft® (MG): The structure of MG was observed in the cross section as a bilayered collagen
matrix. The layers could be differentiated because of their variation in porosity. The compact layer
(CL) was thinner and exhibited lower porosity than the spongy layer (SL; Figure 1A). The surface
of the CL was smooth and even (Figure 1A1). In contrast, the surface of the spongy layer was more
heterogeneous. Collagen fibers of different diameters were observed in a defined arrangement, which
made the surface of the SL rough (Figure 1A2).
Bio-Gide® (BG): In the cross section, the ultrastructure of BG showed two different layers; i.e., the
CL and SL. The arrangement of the collagen fibers allowed the identification and differentiation of the
layers. Most of the collagen fibers in the CL were arranged vertically, which imparted low porosity,
whereas the collagen fibers within the SL were arranged in parallel horizontally direction, which
contributed to its more porous appearance (Figure 1B). The surface of the CL consisted of collagen
fibers that were close to each other, imparting a smooth, even surface with small intercollagenous
spaces and low porosity (Figure 1B1). The SL showed a dynamic distribution of collagen fibers, which
provided a more porous structure and a rather surface (Figure 1B2).
Mucoderm® (MD): In the cross section, MD showed uniformly arranged collagen fibers that
appeared to be tightly interwoven (Figure 1C). The surface structure exhibited a high roughness
(Figure 1C1,C2). The porous system was compact and consistent.
Collprotect® (CP): In cross section, the membrane appeared homogenous, with irregularly
arranged collagen fibers. Different-sized pores were unequally distributed throughout the cross section
(Figure 1D). The surfaces of both sides appeared to be different. The rough side exhibited a very
uneven surface with upward-directed fibers (Figure 1D1). In contrast, the smooth side was comparably
smooth, with fine collagen fibers that formed a slightly wavy surface (Figure 1D2).
BEGO collagen membrane (BCM): A cross section of the BCM showed parallelly-arranged collagen
fibers with uniform porosity (Figure 1E). The surfaces of the membrane differed according to their
morphology. The smooth surface was evenly wavy without obvious pores (Figure 1E1), whereas the
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rough surface was compact but more porous, with collagen fibers arranged in different directions
(Figure 1E2).
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Figure 1. Representative scanning electron microscopy images showing the ultrastructure of the 
evaluated biomaterials. (A) MG in a cross section (×25, 10 Kv, scale bar = 1 mm); (A1) the smooth 
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Figure 1. Representative scanning electron microscopy images showing the ultrastructure of the
evaluated biomaterials. (A) MG in a cross section (×25, 10 Kv, scale bar = 1 mm); (A1) the smooth
surface of MG (×500, 5 kV, scale bar = 50 µm); (A2) the rough surface of MG (×500, 5 kV, scale
bar = 50 µm). (B) Cross section of BG (×200, 10 kV, scale bar = 200 µm); (B1) the smooth surface of BG
(×500, 5 kV, scale bar = 50 µm); (B2) the rough surface of BG (×500, 5 kV, scale bar = 50 µm). (C) Cross
section of MD (×50, 15 kV, scale bar = 500 µm); (C1) the surface of MD (×100, 5 Kv, scale bar = 200 µm);
(C2) the surface of MD at a higher magnification (×500, 5 kV, scale bar = 50 µm). (D) Cross section
of CP (×200, 15 kV, scale bar = 200 µm); (D1) the rough side of CP (×500, 5 kV, scale bar = 50 µm);
(D2) the smooth side of CP (×500, 5 kV, scale bar = 50 µm); (E) cross section of BCM (×500, 15 kV, scale
bar = 50 µm); (E1) smooth surface of BCM (×500, 5 kV, scale bar = 50 µm); (E2) the rough surface of
BCM (×500, 5 kV, scale bar = 50 µm).
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3.2. Histological Evaluation of Material–PRF Interaction
Qualitative histological analysis of each tissues was performed, focusing on the interaction
between the liquid-PR and each collagen-based biomaterial. A particular emphasis was placed on the
distribution of leucocytes and platelets within the biomaterials, and the fibrin saturation.
Mucograft ® (MG): Liquid-PRF was detectable between the collagen fibers of the matrix, and
liquid-PRF had invaded the entire collagen matrix; i.e., the SL and CL (Figure 2a,a1). Additionally, the
pores appeared to be mostly full of liquid-PRF, and the leucocytes and platelets had reached the central
region of the collagen matrix and were evenly distributed. These cells were clearly observable in the
superficial layer and within the core of the membrane. A PRF-clot was observable on the surface of the
matrix (Figure 3a,a1).
Bio-Gide® (BG): After liquid-PRF application, the bilayered collagen membrane showed a variable
distribution pattern. Leucocytes and platelets were located between the collagen fibers on the superficial
parts of the CL (Figure 2b,b1). In contrast, the SL appeared to be largely free of cells. In addition,
there were no leucocytes or platelets in the central region of the collagen membrane. While a stable,
continuous liquid-PRF clot was located adjacent to the surface of the membrane on the SL (Figure 3b,b1),
only a sporadic liquid-PRF was observed on the surface of the CL.
Mucoderm® (MD): Both sides of the biomaterial interacted with the liquid-PRF matrix. However,
the interaction was only observed on the very superficial layers of the membrane (Figure 2c,c1). There
was almost no liquid-PRF invasion within the superficial layers, although some single leucocytes and
platelets were observed (Figure 3c,c1). These cells did not enter the material body or reach the center.
Accordingly, most of the collagenous material contained no fibrin or leucocytes. In addition, some PRF
clot formation was observed on the collagen membrane surface.
Collprotect® (CP): Both sides of the membrane had leucocytes and platelets between the collagen
fibers of the superficial layer (Figure 2d,d1). However, the central region of the membrane was free
of leucocytes and platelets (Figure 3d,d1). Liquid-PRF did not invade the membrane; therefore, no
fibrin was observed in any part of the membrane; however, a PRF clot did form on the surface of
the membrane.
BEGO® collagen membrane (BCM): The liquid-PRF did not enter the collagen membrane.
No leucocytes or platelets were found in any region of the membrane (Figure 2e,e1), and no fibrin was
observed within the membrane. Additionally, the membrane appeared to be embedded within a PRF
clot, without allowing the liquid-PRF to enter the membrane central region (Figure 3e,e1).
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Figure 2. Representative histological icrographs. (a–e) Cross sections of blank e branes ithout
liquid-PRF as a control (all pictures are total scan sections in .E. staining, ×40 agnification, scale
bar = 1000 µm). (a1–e1) Cross sections of membranes after liquid-PRF incubation (all pictures are total
scan sections in hematoxylin and eosin staining, ×40 magnification, scale bar = 1000 µm). (a,a1) G,
(b,b1) BG, (c,c1) MD, (d,d1) CP, and (e,e1) BCM.
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 Figure 3. The interaction between liquid-PRF and the evaluated membranes. (a–e) The formation of
PRF-clots on the membrane (a) or on the membrane surface (b–e). (a–e) Masson Goldner staining,
×100 magnification. Dashed lines refer to the area, which is presented at a higher magnification in
(a1–e1). (a1–e1) A higher magnification of the membrane-cell interaction in the different membrane
types. Arrows point to the cell localization in the different membranes. Giemsa staining at 400×
magnification. (a,a1) MG, (b,b1) BG, (c,c1) MD, (d,d1) CP, and (e,e1) BCM.
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3.3. Histomorphometrical Results of the PRF Penetration Pattern within the Different
Collagen-Based Biomaterials
Cellular penetration of the platelets and leukocytes into the different biomaterials was evaluated
histomorphometrically. The analysis revealed that MG showed the highest percentage of cellular
penetration, and compared to all other evaluated materials, the difference was highly significant
(p < 0.0001 ****). The cellular penetration of BG was significantly higher than that of MD (p < 0.0001 ****),
CP (p < 0.001 ***), and BMC (p < 0.0001 ****). CP showed significantly higher cellular penetration than
BMC (p < 0.05 *). However, there were no statistically significant differences between MD and CP or
MD and BCM (Figure 4).
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Figure 4. Statistical analysis of the cell penetration in percent with regard to the biomaterial thickness.
Statistically significance at p < 0.05 (*) and high significance at p < 0.01 (**), p < 0.001 (***) and
p < 0.0001 (****).
3.4. Water and Liquid-PRF Absorption Coefficient (WAC/PAC) in the Different Collagen-Based Biomaterials
Simil r absorption patterns were observed f r both WAC and PAC. In the case of the WAC, MG
absorbed a significantly higher amount of water compared to BG (**** p < 0.0001), MD (**** p < 0.0001),
CP (**** p < 0.0001), and BCM (**** p < 0.0001). No statistically significant differences were found
between the other groups
For the PAC, the results demonstrated that MG can absorb a high content of liquid-PRF components
and increase its original weight up to 10 times (10.12 ± 1.29). BG increased its weight four times
(4.37 ± 1.50) after being immersed in liquid-PRF. MD showed the lowest PAC with an increase of two
times its original weight (2.83 ± 0.53). CP exhibited a middle range of PAC values with an increase of
five times its weight (5.05 ± 2.21) after immersion in liquid-PRF. In the case of BCM, the measurements
showed an increase of six times its original weight (6.12 ± 0.97). Thereby, MG absorbed significantly
Materials 2019, 12, 3993 11 of 17
more liquid-PRF compared to BG (**** p < 0.0001), MD (**** p < 0.0001), CP (*** p < 0.001), and BCM
(** p < 0.01). No statistical significant differences were found between the other groups (Figure 5).
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Figure 5. (a–e) The different membranes incubated in liquid-PRF: (a) MG, (b) BG, (c) MD, (d) CP,
and (e) BCM. (f) Water absorption coefficient (WAC) and liquid-PRF absorption coefficient (PAC).
Differences were considered statistically significant at p < 0.05 (*) and as highly significant at p < 0.01 (**),
p < 0.001 (***) and p < 0.0001 (****).
3.5. Classification of Collagen Liquid-PRF Interaction
The histological observations allowed the classification of collagen-based biomaterials based
on their interactions with liquid-PRF. Thereby, three different interaction types were observed. MG
allowed total penetration of liquid-PRF into its central region and represented reaction type I (class I).
MD, CP, and BG showed only some penetration of PRF into the collagen-based biomaterials. However,
the central region w s free of liquid-PRF. These materials represented interaction type II (class II).
Finally, BCM was completely occlusive over the penetration of liquid-PRF, and therefore represented a
further, type III i teraction (class III) (Figure 6).
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4. Discussion
The development of biomaterials for use in cell-based tissue engineering has focused on the
in vitro preculturing of biomaterials. This technique showed enhanced vascularization after the
addition of isolated cells, such as endothelial cells, mesenchymal cells, or primary human osteoblasts, in
mono or cocultures [14]. The procedure of cell isolation and preculturing of biomaterials is dependent
on various factors, including harvesting human tissue, cell isolation, and cultivation under aseptic
conditions in laboratories. Precultivation of biomaterials can take up to two weeks [19]. In addition,
cell cultures are sensitive to viral and bacterial infection and environmental changes [20]. These
factors are practical limitations and drawbacks for routine clinical use. With the introduction of
PRF [13,21], scientific developments have met the requirements for clinical application; thus, cell-based
tissue engineering and regeneration have become clinically applicable. In contrast to isolated cells,
PRF is a complex system that includes human platelets, leukocytes, and plasma proteins within a
fibrin matrix [22]. Those co ponents are key ele ents in ound healing and tissue regeneration.
Leukocytes pro ote regeneration by releasing signaling olecules involved in angiogenesis, cellular
cross-talk [15,23], and cell-cell co unication during bone for ation [24]. Platelets are essential for
ound healing and tissue regeneration, as they express nu erous platelet-derived gro th factors
(P Fs), such as vascular endothelial gro th factor ( E F), hich pro otes vascularization, and
transfor ing gro th factor-beta (T F-β), which influences the function of cells involved in ne
tissue for ation, such as fibroblasts [23,25,26]. Thus, the interplay bet een these cells leads to better
perfor ance in regeneration [27]. The so-called lo -speed centrifugation concept (LSCC) leads to
significant enrich ent of liquid-PRF-based atrices ith leukocytes and platelets [16]. Furthermore,
liquid-PRF has a suitable consistency and is easy to handle. The reasoning behind combining collagen
e branes ith liquid-PRF is to make use of the liquid-PRF constituents, such as leukocytes, platelets,
and fibrin, to support guided bone and tissue regeneration (GTR/GBR).
This study presented a histological analysis of the combination of autologous liquid-PRF matrix and
xenogeneic collagen-based biomaterials. However, to date, it is unknown which type of collagen-based
biomaterial is most suitable for combination with liquid-PRF. Therefore, this ex vivo study was the
first to analyze the interaction pattern between PRF and different collagen-based biomaterials with the
aim of understanding the capacity and suitability of biomaterials to incorporate PRF. The results are
potentially useful for translation into specific clinical indications with improved regeneration potential.
The results of the present study showed differences in the structural composition of the collagen
membranes observed by scanning electron microscopy and variations in the interactions between the
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collagen-based biomaterials and liquid-PRF, supporting previous findings that the cellular-biomaterial
interaction is partially determined by the structural characteristics of the biomaterial [28,29].
MG is a collagen matrix composed of a smooth and rough surface. When mixed with liquid-PRF,
the collagen matrix appeared completely loaded with liquid-PRF, including leukocytes, platelets
and fibrin matrix, which were evenly distributed throughout the collagen matrix. Additionally, MG
showed the higher PAC of all the membranes included in this study, ratifying the histological findings.
The present ex vivo results also underlined the ability of MG to serve as an “enriched” scaffold with
liquid-PRF, including cells and fibrin matrix. According to the literature, one of the most common
clinical indications of MG in dentistry is the coverage of periodontal recession defects by GTR. In
a previous clinical study by our group, MG was used to cover skin defects to induce soft tissue
regeneration in patients undergoing skin cancer removal [30]. The histological results revealed an
integrated membrane, inducing a mononuclear cellular reaction and a desirable clinical appearance [30].
The interaction between the collagen-based matrix and liquid-PRF, i.e., complete enrichment of the
collagen matrix with liquid-PRF, may lead to a better tissue regeneration process in clinical applications
as an effect of the regeneration potential of liquid-PRF. However, further clinical studies are required.
BG is a collagen bilayered membrane with one compact and one spongy layer. In this scenario, in
the cell–biomaterial interaction, liquid-PRF showed a different distribution within BG. The CL allowed
cells (leukocytes and platelets) and the fibrin matrix to partially enter the membrane, whereas the SL
was free of liquid-PRF. Therefore, the central region of the material showed no liquid-PRF cellular
penetration. Interestingly, the SL, which was free of liquid-PRF, had a well-adhered liquid-PRF clot
on the surface. The results confirm the primary clinical use for BG, which is GBR. As stated by the
manufacturer, the SL should face the bony defect, and the CL should be adapted to the soft tissue.
Clinically, by applying the “enriched” membrane to a bony defect, BG would preserve its clinical
indication, and the liquid-PRF clot on the surface would face the bony defect to support its regeneration.
In comparison, MD and CP allowed less liquid-PRF intake, as observed histologically and by
the PAC measurements. These collagen-based biomaterials had leukocytes and platelets only in the
most superficial layer. Those cellular–biomaterial interactions could be explained by the biomaterials’
compact structures with fibers of larger size, which were presumably impeding the expansion of
biomaterials and reducing their PAC properties.
MD contained liquid-PRF fibrin between the most superficial collagen fibers, and both biomaterials
showed a stable liquid-PRF clot on their surface. These materials have been used clinically in GBR/GTR.
In this scenario, the result once again confirmed the membranes’ clinical indication for GBR/GTR due
to the observed liquid-PRF formation of a PRF clot on their surface. Remarkably, in a previous in vivo
study by our group using a subcutaneous model in Wistar rats, a pathological cellular reaction lead by
MNGCs was observed on the surface of these liquid-PRF collagen-based biomaterials. The implications
of an enriched collagen biomaterial, i.e., covered with a liquid-PRF clot, as to whether the inflammatory
cellular reaction would be modulated, is a topic of research that requires further investigation.
The final biomaterial tested, BCM, appeared to be surrounded by a large liquid-PRF clot, and
histologically no leukocytes, platelets, or fibrin were observed invading the membrane. Nevertheless,
the PAC measurements of BMC showed an absorbing coefficient of five. These results suggest that
BMC and the aforementioned collagen membranes may have also absorbed other components of
liquid-PRF, which were not the focus of this histological evaluation. According to the manufacturer,
BCM is to be used for GBR/GTR, which is in accordance with the formation of a liquid-PRF clot on
the surface of the membrane. In this context, the adherent liquid-PRF clot would interact with the
surrounding tissue. The rationale behind this cellular-biomaterial interaction liquid-PRF could be
related to the physicochemical characteristics of the biomaterial due to the methods used to sterilize
the membranes. BCM is the only biomaterial investigated in this study that is sterilized with ethylene
oxide gas [7]; the other evaluated membranes are sterilized with gamma irradiation [4–6], which might
influence the physiochemical composition of the biomaterial and its interaction with liquid-PRF.
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Remarkably, MD, CP, and BCM showed commonalities ex vivo. These collagenous materials
prevented the liquid-PRF components from entering the membrane central region, leading to the
formation of a PRF clot on the surfaces. Additionally, the ultrastructural analyses of the various
collagen-based biomaterials showed different characteristics.
It seems that the physiochemical composition and surface properties of these biomaterials are
critical elements for cellular interaction. These characteristics are probably related to the techniques
used to process the biomaterials during manufacturing and the harvesting compartment. The various
interaction patterns observed in this study are of great clinical relevance. Based on the results presented
here, including three different interaction types (class I–III), this approach may be useful as a tool
to further classify and evaluate the capacity of different collagen-based biomaterials to assess their
regenerative capacities. However, this study did not provide any results about the bioactivity of the
different membranes, after combination with PRF. Therefore, further studies are need to further verify
this system.
Interestingly, although all of the biomaterials evaluated here are of porcine origin, variable
interactions with liquid-PRF were observed. Evidently, these differences depended on the biomaterial
properties, since the protocol to obtain liquid-PRF was consistent. Accordingly, the physiochemical
compositions of the particular biomaterials might influence their interactions with inflammatory cells.
Therefore, liquid-PRF might be a useful tool for ex vivo examination of the initial response towards
novel biomaterials to predict the in vivo cellular response.
Previous in vitro studies have shown that PRF-based matrices can be considered delivery systems
because of their ability to release different growth factors [16]. When combining xenogeneic biomaterials
with autologous liquid-PRF, the question raised is to what extent the addition of liquid-PRF, as a
dose of physiological inflammatory cells, can influence the biomaterial-related cellular reaction. It
might be that the total cellular penetration of the biomaterial, including the fibrin matrix within the
collagen matrix, could act as a biomaterial-based delivery system, leading to enhanced vascularization
and tissue regeneration, as the regenerative potential of collagen-based biomaterials and fibrin-based
liquid-PRF are used simultaneously.
Furthermore, the present study utilized a protocol of 600 RPM for 8 min to produce liquid-PRF,
which was previously introduced by the low-speed centrifugation concept [16]. Additionally, a
systematic study investigated the influence of reducing the RCF as a proof of LSCC by using a 3 min
centrifugation time and showed similar results [31]. More recently, it was further shown that the
8 min protocol utilized in our study represents a superior and more effective means to concentrate
platelets compared to many commercially available protocols [32]. Previous studies have described
the role of collagen-based biomaterials as a bioactive compartment in GTR by demonstrating the
effect of placing a collagen membrane on newly formed bone [8,9]. Accordingly, the combination of
liquid-PRF with collagen-based biomaterials introduced in this study aimed to optimize the bioactivity
of biomaterials to achieve better regeneration using a clinically applicable system. The present study
proved that it is possible to load xenogeneic collagen-based biomaterials with a complex mixture of
autologous cells (liquid-PRF) using a clinically applicable method in less than 15 min. Additionally,
we showed a histological analysis of each distribution pattern of liquid-PRF after its application on
various biomaterials. However, the present observations do not provide any information as to what
extent this biologically complex system, i.e., liquid-PRF with various collagen-based biomaterials, will
influence the functionality of the included cells and growth factors. Additionally, the influence of PRF
on the mechanical properties of the biomaterials and the activation of the cells in PRF after contact with
the biomaterial surface must be further evaluated. Thus, ongoing systematic investigations, including
ex vivo, in vivo, and in vitro studies, are needed to evaluate the functionality and potential of this
system. Moreover, controlled clinical studies will provide knowledge about the sufficiency of this
combination system for the regeneration process and its effects on patient morbidity.
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5. Conclusions
The present study analyzed the combination of an autologous liquid-PRF matrix as a drug delivery
system, with five different xenogeneic collagen-based biomaterials histologically. Emphasis was placed
on the distribution of leucocytes and platelets within the collagen membrane, and the interaction
between the collagen membrane and liquid-PRF. Although all of the evaluated membranes were of
porcine origin, three different types of interactions were observed, including total cellular penetration,
partial cellular penetration, and no cellular penetration. The present study showed that it is possible to
load biomaterials with a complex cell system (liquid-PRF) using a clinically applicable method within
15 min. PRF could serve as a drug delivery system to support GTR/GBR and enhance biomaterial
bioactivity. Additionally, this ex vivo system could be used to assess the initial reactions of novel
biomaterials, and thus reduce the number of animals used for in vivo studies. However, further
investigations are required to evaluate the regeneration potential of this combination system and its
clinical impact on patient morbidity.
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